APONTIS PHARMA AG had a revenue of 25.74M in the quarter ending Dec 31, 2024, with 13.26%. This bring the company's revenue in the last twelve months to 48.47M, Decreased 19.28%. In the fiscal year ending Dec 31, 2024, APONTIS PHARMA AG had annual revenue of 48.47M with 31.12% growth.